Align Technology is a global medical device company with industry-leading innovative products -- Invisalign clear aligners and iTero Intraoral scanners that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients.
Invisalign System
Invisalign clear aligners have been used to straighten teeth and treat minor to complex malocclusion. The Invisalign system is a combination of proprietary virtual modeling software and rapid mass-manufacturing processes used to develop a treatment plan and with custom-made aligners for each patient.
The iTero Intraoral scanner provides a dental "chair-side" platform for accessing valuable digital diagnosis and treatment tools, with potential for enhancing accuracy of records, treatment efficiency, and the overall patient experience. The iTero scanner’s parallel confocal imaging technology uses optical and laser scanning to achieve a high level of precision and accuracy resulting in an accurate 3D digital impression image of the patients dentition.
Key People at Align Technology
Thomas M. Prescott
Align Technology Office Locations
Align Technology Data and Metrics
Align Technology Financial Metrics
Revenue (FY, 2016) | 1.1 b |
Revenue growth (FY, 2015 - FY, 2016), % | 28% |
Gross profit (FY, 2016) | 815.3 m |
Gross profit margin (FY, 2016), % | 75% |
Net income (FY, 2016) | 189.7 m |
EBIT (FY, 2016) | 248.9 m |
Market capitalization (27-Jun-2017) | 12 b |
Closing share price (27-Jun-2017) | 151.7 |
Cash (31-Dec-2016) | 389.3 m |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 660.2 m | 761.7 m | 845.5 m | 1.1 b |
Revenue growth, % | 15% | 11% | 28% | |
Cost of goods sold | 162.1 m | 183.2 m | 205.4 m | 264.6 m |
Gross profit | 498.1 m | 578.4 m | 640.1 m | 815.3 m |
Gross profit Margin, % | 75% | 76% | 76% | 75% |
Operating expense total | 403.9 m | 384.9 m | 451.5 m | 566.4 m |
EBIT | 94.2 m | 193.6 m | 188.6 m | 248.9 m |
EBIT margin, % | 14% | 25% | 22% | 23% |
Interest income | 3.2 m | 2.5 m | 6.4 m | |
Income tax expense | 28.8 m | 44.5 m | 42.1 m | 51.2 m |
Net Income | 64.3 m | 145.8 m | 144 m | 189.7 m |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 243 m | 199.9 m | 167.7 m | 389.3 m |
Inventories | 14 m | 15.9 m | 19.5 m | 27.1 m |
Current Assets | 544.7 m | 657.2 m | 732 m | 953 m |
PP&E | 75.7 m | 90.1 m | 136.5 m | 175.2 m |
Goodwill | 61.6 m | 82.1 m | 79.2 m | 82 m |
Total Assets | 832.1 m | 988 m | 1.2 b | 1.4 b |
Accounts Payable | 17.7 m | 23.2 m | 34.4 m | 28.6 m |
Current Liabilities | 175.3 m | 201.8 m | 271.7 m | 354.3 m |
Additional Paid-in Capital | 729.6 m | 783.4 m | 821.5 m | 864.9 m |
Retained Earnings | (95.9 m) | (30.5 m) | 27.4 m | 131.4 m |
Total Equity | 634 m | 752.8 m | 847.9 m | 995.4 m |
Financial Leverage | 1.3 x | 1.3 x | 1.4 x | 1.4 x |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 64.3 m | 145.8 m | 144 m | 189.7 m |
Depreciation and Amortization | 13.9 m | 17.9 m | 18 m | 24 m |
Accounts Receivable | (12 m) | (27 m) | (41 m) | (94 m) |
Inventories | 1.2 m | (2 m) | (3.6 m) | (7.7 m) |
Accounts Payable | (186 k) | 2.9 m | 7.6 m | (3.4 m) |
Cash From Operating Activities | 186 m | 226.9 m | 238 m | 247.7 m |
Cash From Investing Activities | (210.7 m) | (201.6 m) | (166.4 m) | 72.8 m |
Cash From Financing Activities | (38.2 m) | (66.4 m) | (100.8 m) | (95.5 m) |
| Y, 2016 | |
|---|---|
Financial Leverage | 1.4 x |
